skip to main content

What makes (hydroxy)chloroquine ineffective against COVID-19: insights from cell biology

Altulea, Dania ; Maassen, Sjors ; Baranov, Maksim V ; van den Bogaart, Geert Wu, Jiarui

Journal of molecular cell biology, 2021-03, Vol.13 (3), p.175-184 [Periódico revisado por pares]

United States: Oxford University Press

Texto completo disponível

Citações Citado por
  • Título:
    What makes (hydroxy)chloroquine ineffective against COVID-19: insights from cell biology
  • Autor: Altulea, Dania ; Maassen, Sjors ; Baranov, Maksim V ; van den Bogaart, Geert
  • Wu, Jiarui
  • Assuntos: Reviews
  • É parte de: Journal of molecular cell biology, 2021-03, Vol.13 (3), p.175-184
  • Notas: ObjectType-Article-2
    SourceType-Scholarly Journals-1
    ObjectType-Feature-3
    content type line 23
    ObjectType-Review-1
  • Descrição: Since chloroquine (CQ) and hydroxychloroquine (HCQ) can inhibit the invasion and proliferation of SARS-CoV-2 in cultured cells, the repurposing of these antimalarial drugs was considered a promising strategy for treatment and prevention of COVID-19. However, despite promising preliminary findings, many clinical trials showed neither significant therapeutic nor prophylactic benefits of CQ and HCQ against COVID-19. Here, we aim to answer the question of why these drugs are not effective against the disease by examining the cellular working mechanisms of CQ and HCQ in prevention of SARS-CoV-2 infections.
  • Editor: United States: Oxford University Press
  • Idioma: Inglês

Buscando em bases de dados remotas. Favor aguardar.